Estrella Nuñez Delicado

Dr. Estrella Nuñez Delicado

UCAM
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2016 in Nature
Verified
Journal Article
Closed access
PDF file
KSKeiichiro Suzuki
Keiichiro Suzuki
YTYuji Tsunekawa
Yuji Tsunekawa
RHReyna Hernandez-Benitez
Reyna Hernandez-Benitez
JWJun Wu
Jun Wu
JZJie Zhu
Jie Zhu
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte

1 December 2016 in Cell
Verified
Journal Article
Closed access
AOAlejandro Ocampo
Alejandro Ocampo
PRPradeep Reddy
Pradeep Reddy
PMPaloma Martinez-Redondo
Paloma Martinez-Redondo
APAida Platero-Luengo
Aida Platero-Luengo
FHFumiyuki Hatanaka
Fumiyuki Hatanaka
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte

1 January 2017 in Cell
Verified
Journal Article
Closed access
JWJun Wu
Jun Wu
APAida Platero-Luengo
Aida Platero-Luengo
MSMasahiro Sakurai
Masahiro Sakurai
ASAtsushi Sugawara
Atsushi Sugawara
MGMaria Antonia Gil
Maria Antonia Gil
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte

1 December 2017 in Cell
Verified
Journal Article
Closed access
HLHsin-Kai Liao
Hsin-Kai Liao
FHFumiyuki Hatanaka
Fumiyuki Hatanaka
TAToshikazu Araoka
Toshikazu Araoka
PRPradeep Reddy
Pradeep Reddy
MWMin-Zu Wu
Min-Zu Wu
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte

5 September 2018 in Nature
Verified
Journal Article
Closed access
PDF file
MKMasakazu Kurita
Masakazu Kurita
TAToshikazu Araoka
Toshikazu Araoka
THTomoaki Hishida
Tomoaki Hishida
DODavid D. O’keefe
David D. O’keefe
YTYuta Takahashi
Yuta Takahashi
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte

10 August 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
FVFrancesco Della Valle
Francesco Della Valle
PRPradeep Reddy
Pradeep Reddy
MYMako Yamamoto
Mako Yamamoto
PLPeng Liu
Peng Liu
ASAlfonso Saera-Vila
Alfonso Saera-Vila
VOValerio Orlando
Valerio Orlando
Constitutive heterochromatin is responsible for genome repression of DNA enriched in repetitive sequences, telomeres, and centromeres. During physiological and pathological premature aging, heterochromatin homeostasis is profoundly compromised. Here, we showed that LINE-1 ( Long Interspersed Nuclear Element-1; L1 ) RNA accumulation was an early event in both typical and atypical human progeroid syndromes. L1 RNA negatively regulated the enzymatic activity of the histone-lysine N -methyltransferase SUV39H1 (suppression of variegation 3-9 homolog 1), resulting in heterochromatin loss and onset of senescent phenotypes in vitro. Depletion of L1 RNA in dermal fibroblast cells from patients with different progeroid syndromes using specific antisense oligonucleotides (ASOs) restored heterochromatin histone 3 lysine 9 and histone 3 lysine 27 trimethylation marks, reversed DNA methylation age, and counteracted the expression of senescence-associated secretory phenotype genes such as p16 , p21 , activating transcription factor 3 ( ATF3 ), matrix metallopeptidase 13 ( MMP13 ), interleukin 1a ( IL1a ), BTG anti-proliferation factor 2 ( BTG2 ), and growth arrest and DNA damage inducible beta ( GADD45b ). Moreover, systemic delivery of ASOs rescued the histophysiology of tissues and increased the life span of a Hutchinson-Gilford progeria syndrome mouse model. Transcriptional profiling of human and mouse samples after L1 RNA depletion demonstrated that pathways associated with nuclear chromatin organization, cell proliferation, and transcription regulation were enriched. Similarly, pathways associated with aging, inflammatory response, innate immune response, and DNA damage were down-regulated. Our results highlight the role of L1 RNA in heterochromatin homeostasis in progeroid syndromes and identify a possible therapeutic approach to treat premature aging and related syndromes.